Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04656561
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Annexon, Inc. 270
Testing effectiveness (Phase 2)Looking for participantsNCT07160179
What this trial is testing

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
AbbVie 66
Not applicableStudy completedNCT00804102
What this trial is testing

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Who this might be right for
Retinitis PigmentosaMacula OffPrimary Open Angle Glaucoma+8 more
Okuvision GmbH 80
Not applicableStudy completedNCT01977846
What this trial is testing

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Who this might be right for
Stargardt Disease
Foundation Fighting Blindness 259
Not applicableUnknownNCT04469140
What this trial is testing

Non Exudative AMD Imaged With SS-OCT- Extension

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 450
Testing effectiveness (Phase 2)Study completedNCT01002950
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Kubota Vision Inc. 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06510816
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 659
Not applicableStudy completedNCT02800356
What this trial is testing

Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyReticular Pseudodrusen
Ospedale San Raffaele 20
Testing effectiveness (Phase 2)Looking for participantsNCT06394232
What this trial is testing

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

Who this might be right for
Retinal DiseaseMacular DegenerationAge-Related Macular Degeneration+2 more
Eyestem Research Pvt. Ltd. 54
Large-scale testing (Phase 3)Ended earlyNCT00890097
What this trial is testing

Geographic Atrophy Treatment Evaluation

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Alcon Research 772
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705568
What this trial is testing

An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy

Who this might be right for
Geographic AtrophyAge - Related Macular Degeneration (AMD)
Eyevensys 24
Not applicableNot Yet RecruitingNCT07570355
What this trial is testing

Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Shanghai Institute of Acupuncture, Moxibustion and Meridian 62
Not applicableEnrolling By InvitationNCT06745011
What this trial is testing

Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

Who this might be right for
PolyneuropathyAlpha-SynucleinopathyLewy Body Disease+8 more
University of Aarhus 100
Not applicableStudy completedNCT03552484
What this trial is testing

In-Home Care for Patients With PSP and Related Disorders

Who this might be right for
Progressive Supranuclear PalsyDementia With Lewy BodiesMultiple System Atrophy+2 more
Rush University Medical Center 56
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Not applicableUnknownNCT05964634
What this trial is testing

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia

Who this might be right for
MyopiaRefractive ErrorsEye Diseases+2 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 120
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Large-scale testing (Phase 3)Study completedNCT04435366
What this trial is testing

Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Who this might be right for
Geographic AtrophyMacular Degeneration
IVERIC bio, Inc. 448
Not applicableEnded earlyNCT02399072
What this trial is testing

Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 202
Early research (Phase 1)Study completedNCT01064505
What this trial is testing

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Who this might be right for
Optic AtrophyNon-arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 48
Next Page